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An epidemiological study of blood pressure and metabolic
phenotypes in relation to the G3 C825T polymorphism
Eva Branda, Ji-Guang Wangb, Stefan-Martin Herrmannc,d and Jan A. Staessenb
Background The 825T allele of the G-protein 3-subunit
gene is associated with increased intracellular signalling
and adipogenesis in experimental studies. We studied the
C825T polymorphism in relation to blood pressure, obesity
and intermediate phenotypes in a Caucasian population.
Methods We genotyped 737 men and 775 women
(participation rate, 64.3%) enrolled in a Belgian population
study. Dichotomous phenotypes were tested for
association with the C825T polymorphism by Fisher’s
exact test and multiple logistic regression. For continuous
traits, we used analysis of covariance and generalized
estimating equations.
Results The T allele (39.7 versus 29.1%) and TT genotype
(16.1 versus 7.7%) were more prevalent in obese men than
in non-obese men (P < 0.01). TT homozygous men,
compared with C allele carriers, had higher daytime
ambulatory blood pressure (mean systolic/diastolic
differences, 3.6/2.5 mmHg; P < 0.02), higher body weight
(2.7 kg, P 0.04), greater risk of obesity (risk ratio, 1.90;
P 0.005), increased triceps skinfold thickness (2.3 mm,
P 0.007), higher serum insulin concentration (4.1 mU/l,
P 0.006), more insulin resistance (P 0.01), and
increased erythrocyte count (0.11 3 1012 cells/l, P 0.04)
and haematocrit (0.9%, P 0.02). In women, haematocrit
and erythrocyte count were also higher (P < 0.03) in T
allele carriers, but other phenotypes were not correlated
with the C825T polymorphism.
Conclusion Male and female carriers of the T allele at
position 825 of the G-protein 3-subunit gene have a
slightly higher haematocrit and erythrocyte count. Male TT
homozygotes have a higher blood pressure and are more
obese and insulin-resistant than C allele carriers. We
speculate that the higher blood pressure in TT
homozygous men might arise via a metabolic pathway
characterized by obesity and insulin resistance as well as
via increased peripheral resistance secondary to the
higher haematocrit. J Hypertens 21:729–737 & 2003
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Introduction
Guanine nucleotide regulatory proteins (G-proteins) are
part of the intracellular signalling cascades [1]. Their
activation is the principal mechanism through which
stimulated heptahelical receptors generate changes in
intracellular function [1]. Siffert and coworkers identified
a common C825T polymorphism in exon 10 of the 3-
subunit of the heterotrimeric G-protein [2]. The 825T
mutant is associated with a splice variant, which shortens
the protein by 41 amino acids and produces a gain of
function [2]. Increased signalling by G-proteins stimu-
lates adipogenesis [3] and may lead to obesity [4]. In
addition, C825T is a candidate polymorphism for hyper-
tension, because the mutation entails stimulation of the
ubiquitously expressed Naþ/Hþ exchanger [5]. At the
kidney level, this may increase Naþ re-absorption and
cause chronic volume expansion [6]. Prevention of intra-
cellular acidosis may also lead to proliferation of vascular
smooth muscle cells, vascular remodelling and increased
peripheral arterial resistance [6]. However, published
reports on the association between hypertension and the
825T mutation produced inconsistent results [2,7–9].
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There is growing awareness that complex age-related
disorders, such as hypertension, cannot be studied from
an exclusive genocentric point of view, but only within
their epidemiological context [10]. Statistical analyses
should account for factors, such as gender, age, lifestyle,
use of medications, and circadian variability. While
allowing for these influences we studied, in the Flem-
ish Study on Environment, Genes and Health Out-
comes (FLEMENGHO) [11], the G-protein 3-subunit
C825T polymorphism in relation to blood pressure,
obesity and intermediate phenotypes selected because
they may be affected by the variant signalling protein.
Methods
Study population
The Ethics Committee of the University of Leuven
approved the protocol of the FLEMENGHO study.
From August 1985 until November 1990, a random
sample of the households living in a geographically
defined area of Northern Belgium [11] was investigated
with the aim of recruiting an equal number of partici-
pants in each of six subgroups by sex and age (20–
39 years, 40–59 years, and > 60 years). All household
members with a minimum age of 20 years were invited
to take part until the quota of their sex–age group had
been fulfilled. To further study the role of genetic
factors, from June 1996 until January 1998, nuclear
families including children who were at least 10 years
old, were recruited using the former participants
(19851990) as index persons [11]. In 1998 and 1999,
all previously enrolled participants were invited to
donate a blood sample for DNA extraction.
The study population included 2064 persons [11]. The
participation rate among the subjects contacted was
64.3%. The blood pressure of 24 participants was not
measured. In 19981999, blood for DNA extraction
could not be obtained from 403 former participants,
because they did not consent (n ¼ 161) or because they
had died (n ¼ 180), were terminally ill (n ¼ 28), or had
moved out of the area (n ¼ 34). Because of delays
between field and laboratory work or insufficient DNA
amplification, 125 subjects were not genotyped. Thus,
we included 1512 subjects in the present analysis.
Measurement of phenotypes
Study nurses followed the guidelines of the British
Hypertension Society to measure the participants’
sitting blood pressure five times consecutively at each
of two home visits 4–6 weeks apart. For analysis, these
10 blood pressure readings were averaged. Hyper-
tension was diagnosed if the mean was at least
140 mmHg systolic or 90 mmHg diastolic, or when
patients were on antihypertensive medications. The
average daytime blood pressure was determined from
unedited ambulatory recordings with weights according
to the time elapsed between successful readings. Vali-
dated oscillometric SpaceLabs 90202 or 90207 monitors
(Redmond, Washington, USA) were programmed to
obtain measurements at 20-min intervals for at least
12 h between 0800 and 2200 h. For both conventional
and ambulatory blood pressure measurement, standard
cuffs had a 12 3 24 cm inflatable portion, but if the
upper arm girth exceeded 31 cm then cuffs with a
15 3 35 cm bladder were employed.
Weight and height were measured without shoes with
the subjects wearing light indoor clothing. Subjects
were classified as normal, overweight or obese if their
body mass index was , 25.0, 25.0–29.9 or > 30.0 kg/
m2, respectively. Triceps skinfold was determined at
the left arm using a Harpender caliper providing a
constant pressure of 0.01 kg/mm2 ( 10%) at all open-
ings of the 90 mm2 anvils. We administered a validated
[11] questionnaire to collect information about the
subjects’ medical history, use of medications, smoking
habits, intake of alcohol, physical activity, and menstru-
al status of women. From the questionnaire data and
body weight, we estimated energy expenditure due to
physical activity.
In the interval between the two home visits, the
participants collected a 24-h urine sample in a wide-
neck plastic container for measurement of sodium,
potassium and creatinine. A venous blood sample for
the determination of plasma renin activity was obtained
usually within 2 weeks of the urine collection. As
measure of insulin resistance, the homeostasis model
assessment index (HOMA) was calculated from blood
glucose and serum insulin concentrations determined
after an overnight fast [12]. Erythrocytosis was an
erythrocyte count of > 5.5 3 1012 cells/l in men and
> 5.0 3 1012 cells/l in women. The diagnosis of dia-
betes mellitus relied on the medical history confirmed
by each subject’s doctor, on blood glucose concentra-
tions of > 6.1 mmol/l or > 10.0 mmol/l in fasting and
non-fasting conditions, respectively, or on the observa-
tion of glucosuria (. 5.5 mmol/l) by dipstick test on a
fresh urine sample.
Determination of the genotype
Genomic DNA was extracted from white blood cells.
From the published DNA sequence of the G-protein
3-subunit gene [13], we amplified a 268 base pair
fragment incorporating the polymorphic site with use of
two primers as described by Siffert and coworkers [2].
We have previously published the technical procedures,
which we implemented for DNA amplification and
subsequent measurement of the genotypes by allele-
specific hybridization [8].
Statistical methods
For statistical analysis, we used SAS version 8.1 (SAS
Institute, Cary, North Carolina, USA). Continuous
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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measurements with a skewed distribution were normal-
ized by logarithmic transformation and represented by
the geometric mean and its 95% confidence interval
(95% CI). Proportions were compared by Fisher’s exact
test. In each gender separately, we first searched for
possible confounders using stepwise multiple regression
with the P value for co-variables to enter and stay in
the model set at 0.15. We used multiple logistic
regression to test the associations between dichotomous
phenotypes and genotypes while controlling for co-
variables. In logistic regression, genotypes were repre-
sented by dummy variables defined according to the
deviation from the mean coding approach, which does
not imply any genetic hypothesis [14]. Continuous
traits adjusted for co-variables were first analysed by
analysis of covariance. Because in men genetic hetero-
geneity among pathophysiologically related phenotypes
consistently suggested a recessive pattern, we subse-
quently compared TT homozygotes only with C allele
carriers, using the least-square mean option of the
PROC GLM procedure. Finally, we repeated our
analyses using generalized estimating equations [15,16]
to allow for the non-independence of the observations
among related subjects. In the PROC GENMOD
procedure of the SAS package, we defined the intra-
familial correlation matrices based on our own data and




The 1512 participants included 737 men and 775
women (Table 1). One hundred and forty-five (9.6%)
participants were younger than 20 years, 489 were aged
20–39 years (32.3%), 618 (40.9%) were aged 40–59
years, and 260 (17.2%) were 60 years or older. Men and
women had similar age distributions with medians
(interquartile range) of 42.9 years (32.1–55.8 years) and
43.0 years (32.9–56.0 years), respectively (P ¼ 0.82 for
gender difference). The study sample consisted of 762
unrelated individuals including 35 spouse pairs without
offspring, and of 203 families with one to seven
children (327 parents, 423 offspring; median number of
offspring per family, 2).
Mean (standard deviation) body mass index was
25.5 kg/m2 (3.9 kg/m2) in men and 25.2 kg/m2 (5.1 kg/
m2) in women (P ¼ 0.23). Body mass index did not
differ among smokers and non-smokers (25.3 versus
25.6 kg/m2, P ¼ 0.26), but was higher in subjects report-
ing alcohol consumption (26.2 versus 25.1 kg/m2, P ¼
0.0003) or intake of -blockers (27.6 versus 25.4 kg/m2,
P ¼ 0.0003). Hypertension (n ¼ 352, 23.3%), obesity
(n ¼ 193, 12.8%), diabetes mellitus (n ¼ 43, 2.9%) and
erythrocytosis (n ¼ 86, 5.8%) were equally prevalent
(P . 0.28) among men and women. Two hundred and
thirty-two men (31.5%) were current smokers and 245
(33.2%) reported intake of alcohol. Among women,
these numbers were 215 (27.7%) and 88 (11.4%),
respectively. One hundred and forty-seven women
(19.0%) used oral contraceptives and 14 (1.8%) took
hormonal replacement therapy.
Genotype and allele frequencies
The C825T genotype frequencies were 47.3% (n ¼ 715)
for CC, 43.8% (n ¼ 662) for CT, and 8.9% (n ¼ 135) for
TT, and did not deviate from Hardy–Weinberg equili-
brium (P ¼ 0.30). The C and T allele frequencies were
69.2 and 30.8%. According to Fisher’s exact test,
genotype and allele frequencies did not differ according
to the presence or absence of hypertension (Table 2).
These findings remained unaltered if 197 untreated
white-coat hypertensive patients with normal daytime
systolic and diastolic pressures (, 135/, 85 mmHg)
were excluded from analysis. In men, but not in
women, the frequencies of the T allele and the TT
genotype were significantly higher in obese subjects
than in the other participants (P < 0.01; Table 2).
Association analysis in men
Co-variables identified by stepwise regression analysis
are presented in Table 3. Compared with the overall
risk in men, TT homozygous men had a 1.90 (95% CI,
1.21–2.98; P ¼ 0.005) higher risk of obesity (Fig. 1) and
a 1.81 (95% CI, 1.03–3.17; P ¼ 0.04) higher risk of
erythrocytosis (Fig. 2). Conversely, men with the CC
genotype had a lower risk of obesity [risk ratio, 0.61
(95% CI, 0.43–0.86); P ¼ 0.004; Fig. 1].
In unadjusted analyses, the analysis of variance P
values for the continuous phenotypes presented in
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Table 1 Characteristics of participants
Characteristics Men (n ¼ 737) Women (n ¼ 775)
Clinical measurements
Body height (cm) 173.7  7.9 161.5  6.9
Body weight (kg) 77.0  13.0 65.6  13.0
Systolic pressure (mmHg) 125.5  15.2 120.9  16.9
Diastolic pressure (mmHg) 77.0  10.5 74.2  10.3
Pulse rate (beats/min) 67.9  9.6 71.1  10.0
Physical activity (kcal/day)y 1.42 (1.34–1.51) 1.29 (1.22–1.37)
Daytime ambulatory measurements{
Systolic pressure (mmHg) 126.5  10.5 122.1  10.9
Diastolic pressure (mmHg) 77.0  8.4 74.7  7.6
Pulse rate (beats/min) 75.2  11.0 80.7  10.4
Urinary measurements§
Volume (l/day) 1.49  0.60 1.56  0.68
Creatinine (mmol/day) 13.9  3.7 9.4  2.4
Sodium (mmol/day) 201  70 162  58
Potassium (mmol/day) 78  30 64  23
Number (%) on treatment
Antihypertensive drugs 71 (9.6) 102 (13.2)
-Blockers 42 (5.7) 58 (7.5)
Diuretics 25 (3.4) 57 (7.4)
Unless indicated otherwise, values are means  standard deviation.  Individual
values are means of 10 readings, five at each of two separate home visits.
yGeometric mean with 95% CI for 644 men and 684 women. {Means of daytime
(1000–2000 h) measurements in 716 men and 753 women. §720 men and 762
women collected a 24-h urine specimen.
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Table 4 ranged from 0.002 for plasma insulin concentra-
tion or insulin resistance up to 0.11 for systolic blood
pressure at home. With full adjustments applied for
the co-variables presented in Table 3, the analysis of
variance P values in Table 4 were < 0.06 except for
systolic pressure measured at home (P ¼ 0.12). Because
in men genetic heterogeneity among pathophysiologi-
cally related phenotypes consistently suggested a reces-
sive effect of the T allele, we subsequently compared
TT homozygotes with C allele carriers. TT homozygous
men had elevated systolic (129.8 versus 126.2 mmHg,
P ¼ 0.009) and diastolic (79.3 versus 76.8 mmHg,
P ¼ 0.02) daytime ambulatory blood pressures, in-
creased body weight (79.5 versus 76.8 kg, P ¼ 0.04) and
triceps skinfold thickness (14.7 versus 12.4 mm,
P ¼ 0.007), higher serum insulin levels (15.4 versus
11.3 mU/l, P ¼ 0.006), more insulin resistance (HOMA
index, 2.23 versus 1.66; P ¼ 0.01), and increased ery-
throcyte count (4.99 3 1012 versus 4.88 3 1012 cells/l,
P ¼ 0.04) and haematocrit (45.8 versus 44.9%, P ¼
0.02). On the other hand, TT homozygotes compared
with C allele carriers, had similar fasting blood glucose
(5.1 versus 5.0 mmol/l, P ¼ 0.57), plasma renin activity
(0.49 versus 0.43 ng/l per s; P ¼ 0.21), and urinary Naþ/
Kþ ratio (2.90 versus 2.77, P ¼ 0.37).
Using a multiple regression approach, we explored to
what extent body mass index, haematocrit and C825T
genotype explained the variance in daytime blood
pressure. After adjustment for the co-variables pre-
sented in Table 3 as well as for reciprocal effects, body
mass index, haematocrit and C825T genotype, respec-
tively, explained 3.5% (P , 0.0001), 0.8% (P ¼ 0.02)
and 0.6% (P ¼ 0.04) of systolic pressure (model R2 ¼
0.086) and 1.5% (P ¼ 0.001), 0.5% (P ¼ 0.06) and 0.6%
(P ¼ 0.04) of diastolic pressure (model R2 ¼ 0.198).
Association analysis in women
In women (Table 5), both before and after adjustment
for the co-variables presented in Table 3, haematocrit
(P ¼ 0.03) and erythrocyte count (P , 0.001) were
higher in T allele carriers, but none of the other
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Table 2 Genotype and allele frequencies by sex and classes of blood pressure and body mass index
Number of subjects (%) with genotype Number of alleles (%)
Characteristic CC CT TT Py C T Py
Men (n ¼ 737)
Normotension 256 (45.6) 261 (46.5) 44 (7.9) 773 (68.9) 349 (31.1)
Hypertension 91 (51.7) 68 (38.6) 17 (9.7) 0.17 250 (71.0) 102 (29.0) 0.47
Normal weight 162 (49.5) 140 (42.8) 25 (7.7) 464 (70.9) 190 (29.1)
Overweight 153 (47.4) 148 (45.8) 22 (6.8) 454 (70.3) 192 (29.7)
Obese 32 (36.8) 41 (47.1) 14 (16.1) 0.01 105 (60.3) 69 (39.7) 0.007
Women (n ¼ 775)
Normotension 286 (47.8) 250 (41.7) 63 (10.5) 822 (68.6) 376 (31.4)
Hypertension 82 (46.6) 83 (47.2) 11 (6.2) 0.16 247 (70.2) 105 (29.8) 0.60
Normal weight 204 (47.8) 181 (42.4) 42 (9.8) 589 (69.0) 265 (31.0)
Overweight 116 (47.9) 103 (42.6) 23 (9.5) 335 (69.2) 149 (30.8)
Obese 48 (45.3) 49 (46.2) 9 (8.5) 0.80 145 (68.4) 67 (31.6) 0.87
Classification based on the mean of 10 blood pressure measurements at home and World Health Organization/International
Society of Hypertension limits. yFisher’s exact test was used to compare hypertensive with normotensive subjects as well as obese
participants (body mass index > 30.0 kg/m2) with those who had normal body weight (, 25.0 kg/m2) or who were overweight
(25.0–29.9 kg/m2).
Table 3 Co-variables selected in stepwise regression
Phenotypes Co-variables in men and women Additional co-variables in women
Blood pressure at home and
daytime ambulatory pressure
Age, age2, smoking, alcohol intake,
and antihypertensive treatment
Menopause, use of oral
contraceptives
Body weight, body mass index and
triceps skinfold thickness
Age, age2, height (not considered
for body mass index), smoking,
alcohol intake, and use of -
blockers, diuretics or both
Use of oral contraceptives
Plasma renin activity Age, body mass index, smoking,
alcohol consumption, use of -
blockers and diuretics, time of day
of blood sampling, urinary Naþ/Kþ
ratio
Use of oral contraceptives
Erythrocyte count, haematocrit,
plasma insulin, and insulin
resistance
Age, body mass index, smoking,
alcohol consumption, use of -
blockers and diuretics
Use of oral contraceptives
Smoking, alcohol intake, menopause and use of medications were coded 0 or 1 for condition absent or
present.
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phenotypes was correlated with the C825T polymorph-
ism. In particular, body mass index and daytime blood
pressure were neither associated with the T allele in
all women (Table 5) nor in subgroups defined on the
basis of median age (P . 0.27), and/or multiparity
(P . 0.20).
Sensitivity analyses
In men (Table 4) as well as in women (Table 5), the
findings obtained by analysis of co-variance remained
unaltered after exclusion of subjects on antihyperten-
sive treatment or after additional forced adjustments for
physical activity or the presence of diabetes mellitus.
In addition, we also repeated our analyses with similar
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.


































Relative risk of obesity associated with the G-protein 3-subunit
genotype in men. The risk of obesity (body mass index> 30 kg/m2) is
expressed relative to that in all men and is adjusted for age, age2,
smoking, alcohol intake, and the use of -blockers and diuretics.
Vertical lines denote 95% confidence intervals. For each genotype, the
number of subjects is given. The size of the squares is proportional to


































Relative risk of erythrocytosis associated with the G-protein 3-subunit
genotype in men. The risk of erythrocytosis (red blood cell count
> 5.53 1012 cells/l) is adjusted for age, body mass index, smoking,
alcohol intake and the use of -blockers and diuretics. Further
explanation as in Fig. 1.
Table 4 Adjusted phenotypes by G-protein 3-subunit genotype in men
P values
Adjusted G-protein 3-subunit genotypes
Level of
CC CT TT adjustment
n Statistic n Statistic n Statistic None Full
SBP at home (mmHg) 347 125.6  0.8 329 124.9  0.8 61 128.2  1.8 0.11 0.12
DBP at home (mmHg) 347 76.9  0.5 329 76.5  0.5 61 79.3  1.2 0.08 0.05
Daytime SBP (mmHg) 336 126.7  0.6 320 125.7  0.6 60 129.8  1.3 0.009 0.009
Daytime DBP (mmHg) 336 76.9  0.4 320 76.6  0.4 60 79.3  1.0 0.04 0.02
Body weight (kg) 347 76.4  0.5 329 77.3  0.5 61 79.5  1.3 0.06 0.04
Body mass index (kg/m2) 347 25.3  0.2 329 25.6  0.2 61 26.3  0.4 0.13 0.06
Triceps skinfold thickness (mm) 285 12.2  0.4 266 12.6  0.4 52 14.7  0.8 0.008 0.007
Erythrocyte count (1012/l) 339 4.90  0.02 326 4.86  0.02 61 4.99  0.05 0.01 0.04
Haematocrit (%) 338 45.0  0.2 326 44.7  0.2 61 45.8  0.4 0.009 0.02
Plasma insulin (mU/l) 266 11.8 (10.8–13.0) 257 10.7 (9.8–11.8) 51 15.4 (12.5–19.0) 0.002 0.006
Insulin resistancey 111 1.68 (1.53–1.84) 120 1.65 (1.51–1.81) 20 2.23 (1.78–2.79) 0.002 0.01
SBP, systolic blood pressure; DBP, diastolic blood pressure. Values are arithmetic means (standard error) or geometric means (95% confidence interval) adjusted for
the co-variables presented in Table 3. P values denote differences between C allele carriers and TT homozygotes. Full adjustment refers to the co-variables presented
in Table 3. yHomeostasis model assessment index calculated only for fasting subjects as described in [12].
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sets of co-variables as mentioned earlier using general-
ized estimating equations instead of analysis of co-
variance to allow for the non-independence of the
observations within families. Again, these analyses con-
firmed our results.
Discussion
Our epidemiological study tested ‘a priori’ hypotheses
concerning pre-defined phenotype–genotype associa-
tions. However, it was neither designed to disentangle
complex pathophysiological mechanisms nor to prove
causality. Nevertheless, our observations suggest a new
working hypothesis concerning the association between
hypertension and the C825T polymorphism. First, the
mutated 825T allele may increase blood pressure
through a metabolic pathway characterized by the
presence of obesity and insulin resistance [6]. Second,
the higher haematocrit and erythrocyte count associated
with the splice variant may raise blood pressure,
because they increase blood viscosity and resistance to
arteriolar blood flow [17] or because they increase
oxygen delivery to peripheral tissues, thereby leading
to arterial vasoconstriction [18].
Studies of possible association between various cardio-
vascular phenotypes and the C825T polymorphism of
the G-protein 3-subunit gene produced inconsistent
results. The mutated 825T allele was associated with
higher blood pressure [7–9,19] or increased risk of
hypertension [2,8,20,21] in Germans [2,7,9,20], Austra-
lian white hypertensive patients [19], and Caribbean or
West African blacks [21], but not in French [8], Irish
[8], Japanese [22,23], or African-Americans [24]. Few of
the aforementioned studies reported analyses stratified
by gender [9,19]. Only one smaller study in Canadian
Oji-Cree noticed significantly lower systolic and diasto-
lic blood pressures in TT homozygotes than in C allele
carriers [25]. Among hypertensive patients, left ventri-
cular hypertrophy [26] or impaired left ventricular
diastolic filling [27] were linked with the mutated G-
protein 3-subunit allele in Spanish [26] and in Ger-
mans [27]. These discordant cardiovascular findings
suggest that ethnic and genetic background [4], life-
style and various environmental factors may modulate
the small effect of the C825T allele on blood pressure.
The frequency of the T allele was 0.31 in our Caucasian
population, but approximately 0.50 in Japanese [22,23]
or native Americans [25,28], and 0.75 in blacks [21,24].
Another reason for the divergent findings with regard to
blood pressure may reside in the fact that this pheno-
type is more distant from the C825T genetic poly-
morphism than the intermediate haematological and
metabolic factors, which may contribute to the rise in
blood pressure, but for which many counter-regulatory
mechanisms may compensate.
We observed thickening of the triceps skinfold, slightly
higher body mass index and body weight and higher
risk of obesity in TT homozygous men. Increased
signalling by pertussis-toxin-sensitive G-proteins stimu-
lates adipogenesis [3]. Published reports on the associa-
tion between measures of obesity [4] and the G-protein
3-subunit C825T polymorphism are more consistent
than those on hypertension. Several studies [4] demon-
strated that the 825T homozygous genotype was posi-
tively associated with obesity or higher body mass
index in blacks, Caucasians and Chinese. Primiparous
TT homozygotes are at increased risk of obesity and
post-pregnancy obesity [29]. Siffert speculated that the
825T allele predisposes to obesity and hypertension via
hyperinsulinaemia [6]. In line with this hypothesis, we
found higher plasma insulin concentrations and more
insulin resistance in TT homozygous men.
To the best of our knowledge, we are the first to report
slight increases in haematocrit and erythrocyte count in
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Table 5 Adjusted phenotypes by G-protein 3-subunit genotype in women
Adjusted G-protein 3-subunit genotypes
CC CT TT
Characteristic n Statistic n Statistic n Statistic
SBP at home (mmHg) 368 120.3  0.7 333 121.7  0.8 74 120.3  1.6
DBP at home (mmHg) 368 73.7  0.5 333 74.6  0.5 74 74.8  1.1
Daytime SBP (mmHg) 363 121.7  0.5 318 122.4  0.6 72 122.5  1.2
Daytime DBP (mmHg) 363 74.1  0.4 318 75.4  0.4 72 74.1  0.9
Body weight (kg) 368 65.9  0.6 333 65.2  0.7 74 66.0  1.4
Body mass index (kg/m2) 368 25.3  0.2 333 25.1  0.3 74 25.4  0.5
Triceps skinfold thickness (mm) 291 2.14  0.04 262 2.18  0.04 62 2.09  0.09
Erythrocyte count (1012/l) 357 4.40  0.02 329 4.48  0.02 74 4.51  0.04
Haematocrit (%) 357 40.6  0.2 329 41.2  0.2 74 41.2  0.4
Plasma insulin (mU/l) 276 11.9 (10.9–13.0) 250 12.1 (11.0–13.3) 58 11.8 (9.8–14.4)
Insulin resistance 124 1.64 (1.51–1.79) 111 1.63 (1.49–1.79) 26 1.64 (1.35–1.98)
SBP, systolic blood pressure; DBP, diastolic blood pressure. Values are arithmetic means (standard error) or geometric means (95%
confidence interval) adjusted for the co-variables presented in Table 3. Before and after adjustment for the co-variables presented in
Table 3, P values for differences across genotypes were non-significant with the exception of erythrocyte count (P , 0.001) and
haematocrit (P ¼ 0.03).
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association with the G-protein 3-subunit 825T allele.
Long-term increase in haematocrit leads to vasocon-
striction-dependent hypertension, which is character-
ized by elevated cytoplasmic calcium concentration in
vascular smooth muscle cells and by resistance to the
vasodilatory action of nitric oxide [18]. Erythropoietin
is the major regulator of the proliferation and differ-
entiation of erythroid progenitor cells. Promotion of cell
growth by erythropoietin [30,31] is primarily mediated
via activation of the JAK/STAT pathway involving a
specific set of cytosolic tyrosine kinases (JAKs) and
transcription factors (STATs), and via stimulation of
various protein kinase C isoforms. However, molecular
studies also produced evidence for the involvement of
heterotrimeric G-proteins in erythropoiesis [31–35]. Gi-
proteins are associated with the C-terminal end of the
erythropoietin receptor [32]. Activation of this receptor
leads to dissociation of the Gi-protein, suggesting a
functional role of the Gi-protein in signal transduction
[32]. Upon stimulation of the erythropoietin receptor,
G-proteins mediate a dose-dependent increase in cyto-
solic calcium via voltage-independent calcium channels
[33]. Moreover, in human erythroid progenitor cells, G-
proteins inhibit the antiproliferative effects of the
activated thrombin receptor [31,34,35]. Thus, although
the exact molecular pathways still need further clarifica-
tion, experimental evidence supports the concept that
the G-protein 3-subunit C825T polymorphism may be
associated with significant, albeit small, changes in
erythropoiesis [31–35].
Adjustment for body mass index, haematocrit or both
factors did not completely remove the effect of the
C825T polymorphism on the daytime ambulatory blood
pressure in men. Mechanisms other than those pro-
posed might therefore also play a role. At the kidney
level, stimulation of the Naþ/Hþ exchanger may in-
crease Naþ re-absorption and cause chronic volume
expansion with a compensatory inhibition of plasma
renin activity [6]. In keeping with this hypothesis [6],
one population-based study [7] reported a significantly
lower plasma renin activity in the presence of the T
allele. Furthermore, Turner and colleagues [36] ob-
served in patients with essential hypertension that
systolic and diastolic blood pressures declined 5–6
mmHg more in response to diuretic treatment in TT
homozygotes than in CC homozygotes. Zeltner and
associates [5] found in young men with normotension
or mild incipient essential hypertension that carriers of
the 825T allele had a faster tubular sodium re-absorp-
tion than CC homozygotes. Although we did not ob-
serve a significant decrease in plasma renin activity in T
allele carriers, our study does not exclude chronic
sodium retention [5,6] as a pathway underlying the
higher blood pressure in TT homozygous men. Other
possible mechanisms involve altered intracellular sig-
nalling after Æ-adrenergic or -adrenergic receptor sti-
mulation [1]. Current knowledge does not allow one to
differentiate between the involvement of distinct G-
protein subunits and their isoforms in pathophysiologi-
cal processes, but the 3-subunit is widely distributed
across most tissues.
Before we engaged in the statistical analysis, we
planned to analyse men and women separately. Indeed,
blood pressure is an age-related trait with a gender-
specific time course during life. Syndrome X is more
prevalent among men than women [37]. Furthermore,
several studies involving other known candidate genes
revealed gender-specific associations with blood pres-
sure. For instance, in two large-scale population studies
[38,39], the risk of hypertension was related to the
deletion polymorphism of the angiotensin-converting
enzyme in men, but not in women. We previously
found that, in our Flemish population, CC homozygos-
ity at position 1797 of the -adducin gene was asso-
ciated with a lower risk of hypertension in women, but
not in men [40].
Our sample size was sufficiently large to accommodate
sex-specific analyses [16]. The biological consistency
among men in the direction of the phenotypic changes
associated with the TT genotype may be due to the
intrinsic features of the metabolic syndrome [37]. On
the other hand, the coherence and plausibility of the
latter results can also be interpreted as evidence
arguing against a type-1 error due to chance. Conver-
sely, our null findings in women with regard to blood
pressure and obesity might be due to a type II error.
However, sample size calculations performed by Tre´-
goue¨t and colleagues [16] demonstrated that 650 un-
related subjects are sufficient to detect, with 90%
power, an association with an allele, which has a
frequency of 30% and explains 1.6% of the variance of
a continuous phenotype. In similarly informed calcula-
tions involving either families with two offspring or
mixed populations consisting of related and unrelated
people, 650 subjects still provided 85–88% power,
regardless of whether the analysis accounted for family
structure. Sexual dimorphism exists in the heritability
of blood pressure [41]. It is, therefore, conceivable that
our null findings in women are due to a modification of
the genetic effect, for instance by female sex hormones.
Oestradiol increases inositol triphosphate formation via
a signalling process that is linked to a pertussis-toxin-
sensitive G-protein [42]. Moreover, oestradiol acutely
and chronically behaves as a vasodilator [43].
Our findings did not evolve from a post-hoc hypothesis,
neither in terms of the selected phenotype–genotype
associations nor in terms of the separate analysis of
men and women. Nevertheless, our results must be
interpreted within the context of their limitations.
They hinged on the differences between male C allele
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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carriers and TT homozygotes. Among men, the fre-
quency of the TT genotype amounted to 8.3%. Only 20
TT homozygous men were available for the study of
insulin sensitivity. Furthermore, with adjustments for
co-variables applied, the increases in diastolic blood
pressure, body weight, erythrocyte count and haemato-
crit in TT homozygous men were only borderline
significant. P values are key in guiding statistical
inference, but should also be interpreted within the
context of pathophysiological plausibility [44]. With
these limitations in mind, our findings should be
viewed as hypothesis-generating and require further
confirmation in sufficiently powered epidemiological
studies, especially in populations with a higher preva-
lence of the T allele [4].
In conclusion, male and female carriers of the T allele
at position 825 of the G-protein 3-subunit gene have a
slightly higher haematocrit and erythrocyte count. Male
TT homozygotes have a higher blood pressure and are
more obese and insulin-resistant than their C allele
counterparts. We speculated that increased G-protein-
mediated signalling upon stimulation of the erythro-
poietin or thrombin receptor of erythroid progenitor
cells might explain the higher haematocrit and erythro-
cyte count associated with the T allele. Furthermore,
the higher blood pressure in TT homozygous men
might be brought about via a metabolic pathway
characterized by obesity and insulin resistance as well
as via increased peripheral arterial resistance secondary
to the higher haematocrit.
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